JINYU BIO-TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.94 CNY | -3.35% |
|
-13.12% | -16.99% |
| Sales 2024 * | 1.85B 255M | Sales 2025 * | 2.33B 322M | Capitalization | 9.99B 1.38B |
|---|---|---|---|---|---|
| Net income 2024 * | 363M 50.13M | Net income 2025 * | 461M 63.66M | EV / Sales 2024 * | 4.47 x |
| Net cash position 2024 * | 1.73B 239M | Net cash position 2025 * | 1.5B 207M | EV / Sales 2025 * | 3.64 x |
| P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
21.7
x | Employees | 1,654 |
| Yield 2024 * |
1.08% | Yield 2025 * |
1.37% | Free-Float | 80.2% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.35% | ||
| 1 week | -13.12% | ||
| 1 month | -2.19% | ||
| 3 months | +3.11% | ||
| 6 months | -12.70% | ||
| Current year | -16.99% |
1 week
8.87
10.35
1 month
8.8710.95
Current year
6.9410.95
1 year
6.9411.03
3 years
6.9420.19
5 years
6.9431.15
10 years
6.9431.15
| Managers | Title | Age | Since |
|---|---|---|---|
Min Peng
DFI | Director of Finance/CFO | 38 | 21-04-30 |
Jing Zhang
PSD | President | 41 | - |
Yi Kun Liu
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhen Ping Wu
BRD | Director/Board Member | 56 | 22-05-30 |
Chong Yu Zhang
CHM | Chairman | 70 | 04-05-26 |
Chang E Shen
BRD | Director/Board Member | 61 | 19-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +3.86% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 8.94 | -3.35% | 27,219,270 |
| 24-05-30 | 9.25 | -2.84% | 22,961,110 |
| 24-05-29 | 9.52 | -0.73% | 16,379,580 |
| 24-05-28 | 9.59 | -4.96% | 33,988,530 |
| 24-05-27 | 10.09 | -1.94% | 26,171,660 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotes
JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy products.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
8.94
CNY
Average target price
9.38
CNY
Spread / Average Target
+4.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.99% | 1.38B | |
| +18.66% | 8.74B | |
| +23.75% | 3.67B | |
| -0.42% | 3.25B | |
| +18.07% | 1.73B | |
| -0.39% | 1.31B | |
| -26.05% | 1.24B | |
| -17.86% | 1.07B | |
| -6.77% | 976M | |
| -2.89% | 892M |
- Stock Market
- Equities
- 600201 Stock
